Peter tonge
at BlueRock Therapeutics- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
BlueRock Therapeutics
-
United States
-
Biotechnology Research
-
300 - 400 Employee
-
-
Aug 2021 - Present
Responsible for the development of technologies and GMP compliant procedures to establish clinical grade pluripotent stem cell lines. Leading the subsequent generation of genetically engineered PSC lines in compliance with cleanroom manufacturing procedures and regulatory requirements. Liaise with program core teams, coordinating the derivation and MCB/WCB production of program specific engineered PSC lines, tailor made for each therapeutic requirement.Supporting accelerated timelines of cell line development for pipeline of PSC-derived therapies and partnered programs. Providing transparent communication of risks, project milestones and budgets. Show less
-
-
-
Jan 2021 - Jul 2021
-
-
-
Jan 2019 - Dec 2020
-
-
-
Oct 2017 - Dec 2018
-
-
-
CCRM
-
Biotechnology Research
-
100 - 200 Employee
-
-
Mar 2017 - Sep 2017
-
-
-
Sep 2016 - Mar 2017
......
-
-
-
Princess Margaret Cancer Centre
-
Toronto, Canada Area
-
Scientific Associate
-
Jul 2014 - Aug 2016
-
-
-
Mount Sinai Hospital (Toronto), Sinai Health
-
Canada
-
Hospitals and Health Care
-
700 & Above Employee
-
Post doctoral Fellow
-
Dec 2008 - Jul 2014
-
-
Education
-
The University of Sheffield
PhD, Stem cell biology -
The University of Sheffield
Bachelor of Science, Anatomy and Cell Biology